Vendor Warnings

medvi.com

• •
  800+ fake doctor accounts on Facebook — Business Insider reported MEDVi created over 800 fake Facebook doctor personas to advertise GLP-1 products and circumvent Meta's healthcare advertising restrictions. At peak, more than 5,000 simultaneous ads ran through this network before the operation was exposed.
• •
  AI-generated before/after testimonials — MEDVi used AI-generated or altered images as customer testimonials — fabricated social proof in a category where buyers are making real health decisions based on results claims.
• •
  FDA warning letter for false approval claims — The FDA issued a formal warning letter to MEDVi for falsely implying its compounded drugs were FDA-approved and that the company compounded its own medications. Neither claim was accurate.
• •
  Misleading media endorsement logos — MEDVi displayed media logos implying endorsement from outlets that had not endorsed them — a credibility signal regulators characterized as misleading to consumers.

paradigmpeptides.com

• •
  AI-generated product images — Product photos show clear signs of AI generation (artifacts, inconsistent details), suggesting the vendor may not have real inventory or facilities to photograph.
• •
  Selling GLP-1 peptides as oral pills — GLP-1 receptor agonist peptides (semaglutide, tirzepatide) are not bioavailable when taken orally in simple capsule form. Legitimate vendors sell these as lyophilized powder for reconstitution and subcutaneous injection.